FORA Capital LLC purchased a new stake in Trupanion, Inc. (NASDAQ:TRUP – Free Report) during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 12,869 shares of the financial services provider’s stock, valued at approximately $540,000.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Renaissance Technologies LLC bought a new position in shares of Trupanion in the 2nd quarter valued at about $4,739,000. Marshall Wace LLP lifted its holdings in Trupanion by 11.9% in the second quarter. Marshall Wace LLP now owns 1,094,589 shares of the financial services provider’s stock valued at $32,181,000 after buying an additional 116,496 shares during the period. Connors Investor Services Inc. boosted its stake in Trupanion by 31.3% in the second quarter. Connors Investor Services Inc. now owns 113,567 shares of the financial services provider’s stock valued at $3,339,000 after acquiring an additional 27,042 shares during the last quarter. Dalton Investments Inc. acquired a new stake in Trupanion during the 2nd quarter worth $1,029,000. Finally, OmniStar Financial Group Inc. bought a new stake in shares of Trupanion during the 3rd quarter valued at $535,000.
Trupanion Trading Down 1.6 %
Shares of TRUP opened at $53.50 on Friday. Trupanion, Inc. has a twelve month low of $19.69 and a twelve month high of $57.90. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.40. The firm’s 50 day moving average price is $49.73 and its two-hundred day moving average price is $40.06.
Analysts Set New Price Targets
TRUP has been the topic of several recent research reports. Bank of America raised their price target on Trupanion from $47.00 to $56.00 and gave the stock a “buy” rating in a research report on Friday, September 20th. Stifel Nicolaus boosted their target price on Trupanion from $30.00 to $40.00 and gave the stock a “hold” rating in a research report on Monday, September 23rd. Evercore ISI upgraded shares of Trupanion to a “strong-buy” rating in a research report on Friday, August 9th. Piper Sandler boosted their price objective on shares of Trupanion from $45.00 to $57.00 and gave the company a “neutral” rating in a report on Thursday, October 31st. Finally, Northland Securities increased their target price on shares of Trupanion from $45.00 to $50.00 and gave the stock a “market perform” rating in a report on Thursday, October 31st. Three equities research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $44.67.
Get Our Latest Stock Report on Trupanion
Insiders Place Their Bets
In related news, CFO Fawwad Qureshi sold 622 shares of the company’s stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $52.61, for a total transaction of $32,723.42. Following the sale, the chief financial officer now owns 9,867 shares in the company, valued at approximately $519,102.87. This represents a 5.93 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, SVP Emily Dreyer sold 3,100 shares of the stock in a transaction that occurred on Friday, November 22nd. The shares were sold at an average price of $54.85, for a total value of $170,035.00. Following the completion of the sale, the senior vice president now directly owns 24,708 shares of the company’s stock, valued at approximately $1,355,233.80. The trade was a 11.15 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 18,538 shares of company stock valued at $988,741 in the last quarter. 5.50% of the stock is currently owned by insiders.
About Trupanion
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Featured Stories
- Five stocks we like better than Trupanion
- What Makes a Stock a Good Dividend Stock?
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- What is a Special Dividend?
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- Low PE Growth Stocks: Unlocking Investment Opportunities
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Want to see what other hedge funds are holding TRUP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Trupanion, Inc. (NASDAQ:TRUP – Free Report).
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.